GMP Deal Makes Stifel More Accessible to U.S. Clients, CEO Kruszewski Says

The transcript discusses GMP's involvement in the Canadian and US cannabis markets, highlighting the acquisition of GMP's capital markets business by Stifel. It explores GMP's expertise in cannabis and energy, the motivations behind the acquisition, and the expected synergies. The conversation also touches on the financial aspects of the deal and the broader impact on clients and markets.

In what ways does GMP plan to be relevant to small and midcap Canadian companies?

What synergies are expected from the deal?